Here's Why Chimerix, Inc. (CMRX) Is Skyrocketing

Yahoo FinanceJan 13 16:21 ET

Chimerix to Speak Today at The White House Cancer Moonshot Forum

ChimerixJan 13 00:00 ET

Chimerix Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

Dow JonesDec 30, 2024 10:45 ET · Ratings

JonesTrading Maintains Chimerix(CMRX.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsDec 30, 2024 09:31 ET · Ratings

Chimerix Announces NDA Submission For Dordaviprone - Quick Facts

RTTNewsDec 30, 2024 07:28 ET

Chimerix Seeks Accelerated FDA Approval for Experimental Tumor Drug

MT NewswiresDec 30, 2024 07:26 ET